VMD Stock Risk & Deep Value Analysis
Viemed Healthcare Inc
Healthcare • Medical Devices
DVR Score
out of 10
What You Need to Know About VMD Stock
We analyzed Viemed Healthcare Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran VMD through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Moderate. Here's what we found.
VMD Risk Analysis & Red Flags
What Could Go Wrong
The biggest risk for Viemed Healthcare is regulatory changes impacting reimbursement rates for its core services, particularly ventilator rentals and other respiratory therapies. A significant reduction in government or private insurance payouts could severely impact revenue and profitability, despite strong operational execution.
Risk Matrix
Overall
Moderate
Financial
Low
Market
Medium
Competitive
Medium
Execution
Medium
Regulatory
High
Red Flags
- ⚠
Concentration of revenue within government programs (Medicare/Medicaid) or specific private payers could expose the company to reimbursement risks.
- ⚠
While gross margin improved, net margin declined YoY, suggesting potential cost pressures or one-time gains in prior periods that could impact future comparisons.
Upcoming Risk Events
- 📅
Potential changes in Medicare/Medicaid reimbursement policies for home health services
- 📅
Increased competition from larger healthcare providers entering the home care space
- 📅
Economic downturn impacting discretionary healthcare spending
When to Reconsider
- 🚪
Exit if quarterly revenue growth falls below 10% YoY for two consecutive quarters, indicating a slowdown in market penetration or increased competitive pressure.
- 🚪
Sell if gross margin consistently drops below 50%, signaling pricing pressure or increased cost of goods sold.
- 🚪
A sustained decrease in free cash flow, particularly if accompanied by an increase in net debt.
Unlock VMD Risk Analysis & Red Flags
Create a free account to see the full analysis
What Does Viemed Healthcare Inc (VMD) Do?
Market Cap
$358.45M
Sector
Healthcare
Industry
Medical Devices
Employees
1,258
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management that provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Visit Viemed Healthcare Inc WebsiteInvestment Thesis
Viemed Healthcare is a compelling high-growth opportunity positioned to capitalize on the secular shift towards home-based healthcare, particularly in respiratory and chronic care. With robust revenue growth, improving gross margins, exceptional balance sheet strength (no net debt), and growing free cash flow, the company is undervalued relative to its growth profile. Strong execution, evidenced by raised guidance and an active share repurchase program, further reinforces its path to significant market share gains and substantial multiple expansion.
Is VMD Stock Undervalued?
Unlock the full AI analysis for VMD
Get the complete DVR score, risk analysis, and more
Unlock the full report
Create a free account to see the DVR score, risk flags, and AI analysis.
VMD Price Targets & Strategy
12-Month Target
$21.50
Bull Case
$28.00
Bear Case
$15.00
Valuation Basis
Based on 12x forward 2026 Adjusted EBITDA applied to $67M (mid-point of guidance) est. 2026 Adj. EBITDA = $804M market cap, or $21.50/share (assuming ~37.4M shares outstanding).
Entry Strategy
Consider dollar-cost averaging between $8.50 and $9.50. The current price is near recent lows, presenting an attractive entry for a growth company with strong fundamentals. Look for dips towards previous support levels around $8.70.
Exit Strategy
Take initial profits at $21.00-$22.00. Re-evaluate position for long-term 10x potential. Implement a stop-loss order if the stock breaks below $7.50, indicating a significant change in market sentiment or fundamentals.
Portfolio Allocation
7-10% for aggressive risk tolerance, 3-5% for moderate risk tolerance, given its small-cap nature and high growth potential.
Price Targets & Strategy
Sign up free to unlock price targets and entry/exit strategies
Is VMD Financially Healthy?
Valuation
P/E Ratio
24.07
Forward P/E
24.40
PEG Ratio
0.83
Price/Book
2.53
Price/Sales
1.24
Profitability
Gross Margin
57.58%
Operating Margin
8.17%
Net Margin
5.20%
Return on Equity
10.66%
Revenue Growth
23.10%
EPS
$0.37
Balance Sheet
Current Ratio
1.18
Quick Ratio
0.96
Debt/Equity
0.09
Cash Flow
Operating Cash Flow
$8.10M
EBITDA
$14.30M
Other
Beta (Volatility)
1.14
Does VMD Have a Competitive Moat?
Sign in to unlockMoat Rating
🛡️ Narrow
Moat Trend
Expanding
Moat Sources
3 Identified
Viemed's moat is durable due to the high switching costs associated with chronic care management, where continuity of specialized service is paramount. The integration of technology for remote patient monitoring and clinical support further strengthens this, making it difficult for competitors to replicate the full-service, tech-enabled model without significant investment and expertise.
Moat Erosion Risks
- •Rapid technological advancements by competitors that could offer superior or more cost-effective solutions.
- •Changes in patient preferences or regulatory mandates that could reduce the importance of current service offerings.
VMD Competitive Moat Analysis
Sign up to see competitive advantages
VMD Market Intelligence
Sentiment & Insider Activity
Social Sentiment
Neutral. Limited specific data provided on broad retail investor sentiment, but general interest in healthcare technology is positive.
Institutional Sentiment
Positive. Stonegate Capital Partners updated coverage with implied positive outlook, and the share repurchase program suggests institutional conviction. No specific recent analyst upgrades/downgrades were included in the provided sources.
Insider Activity (Form 4)
The company has an active share repurchase program, indicating management's confidence and belief that shares are undervalued.
Options Flow
Normal options activity; no specific unusual options flow data was provided in the research.
Earnings Intelligence
Next Earnings
Estimated early August 2026 for Q2 2026
Surprise Probability
High. The Q1 2026 results and raised guidance suggest strong operational momentum and potential for future beats.
Historical Earnings Pattern
Based on the Q1 2026 release, strong results and guidance typically lead to positive stock price reactions, especially given the current low valuation multiples.
Key Metrics to Watch
Competitive Position
Top Competitor
ResMed Inc. (RMD) or AdaptHealth Corp. (AHCO) (general home healthcare/respiratory peers, not directly specified in research)
Market Share Trend
Gaining. Consistent 20%+ revenue growth across multiple segments indicates successful market penetration and share capture in expanding home health markets.
Valuation vs Peers
Currently trading at a significant discount to peers based on forward P/S (approx. 1.1x) and EV/EBITDA (approx. 5.2x), especially considering its 20%+ revenue growth and strong financial health.
Competitive Advantages
- •Integrated tech-enabled care model combining advanced technology with specialized clinical expertise.
- •Focus on high-acuity respiratory care (e.g., ventilator rentals) creates higher barriers to entry.
- •Scalable operational infrastructure allowing for efficient growth.
Market Intelligence
Sign up free to unlock sentiment, earnings intel, and peer analysis
What Could Drive VMD Stock Higher?
Near-Term (0-6 months)
- •Q2 2026 Earnings Report (estimated early August 2026)
- •Further updates to 2026 financial guidance (potential upward revisions)
- •Increased share repurchase activity
Medium-Term (6-18 months)
- •Expansion into new geographic markets or service lines within home healthcare
- •Strategic partnerships with major healthcare providers or payers
- •Increased adoption of value-based care models driving demand for home health
Long-Term (18+ months)
- •Continued demographic shift towards aging population requiring chronic care at home
- •Disruption of traditional inpatient care models through tech-enabled home health
- •Establishment as a market leader in integrated chronic care management
Catalysts & Growth Drivers
Sign up free to see growth catalysts
What's the Bull Case for VMD?
- ✓
Acceleration in organic revenue growth beyond current guidance.
- ✓
Further expansion of adjusted EBITDA margins and free cash flow conversion rates.
- ✓
Announcements of new strategic partnerships or significant contract wins.
Bull Case Analysis
Sign up free to see the bull case
Competing with VMD
See how Viemed Healthcare Inc compares to related companies
| Company | Market Cap | DVR Score | P/E | Revenue | Profit Margin | Rev Growth | |
|---|---|---|---|---|---|---|---|
Viemed Healthcare Inc VMD | $358.4M | 9.1 | 24.1 | $75.4M | 5.2% | 23.1% | |
AbbVie Inc ABBV | $381.1B | 0.1 | 104.8 | $15.0B | 5.8% | 9.5% | Compare → |
Johnson & Johnson JNJ | $557.1B | 1.0 | 26.5 | — | 21.8% | 7.9% | Compare → |
Eli Lilly and Co LLY | $965.0B | 0.5 | 52.6 | — | — | — | Compare → |
Pfizer Inc PFE | $146.4B | 4.0 | 19.5 | $62.6B | 11.8% | 1.4% | Compare → |
UnitedHealth Group Inc UNH | $365.5B | 0.3 | 30.3 | $447.6B | 2.7% | 9.7% | Compare → |
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
How Viemed Healthcare Inc Makes Money
Viemed Healthcare provides comprehensive, tech-enabled home medical equipment and services, primarily focusing on respiratory, sleep, and maternal health conditions. They make money by renting medical equipment, such as ventilators and sleep apnea devices, to patients for home use, and by providing related clinical services like remote patient monitoring, respiratory therapy, and patient education. This integrated model combines advanced technology with specialized clinical support to deliver higher-quality and more cost-effective care outside of traditional hospital settings.
Read Full Business Model BreakdownFAQ
What is the DVR Score for Viemed Healthcare Inc (VMD)?
As of May 16, 2026, Viemed Healthcare Inc has a DVR Score of 9.1 out of 10, placing it in the "Hidden Gem" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.
What is the market capitalization of Viemed Healthcare Inc?
Viemed Healthcare Inc's market capitalization is approximately $358.4M. The company operates in the Healthcare sector within the Medical Devices industry.
What ticker symbol does Viemed Healthcare Inc use?
VMD is the ticker symbol for Viemed Healthcare Inc. The company trades on the NCM.
What is the risk level for VMD stock?
Our analysis rates Viemed Healthcare Inc's overall risk as Moderate. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.
What is the P/E ratio of VMD?
Viemed Healthcare Inc currently has a price-to-earnings (P/E) ratio of 24.1. This is in line with broader market averages.
Is Viemed Healthcare Inc's revenue growing?
Viemed Healthcare Inc has reported revenue growth of 23.1%. The company is showing strong top-line momentum.
Is VMD stock profitable?
Viemed Healthcare Inc has a profit margin of 5.2%. The company is profitable but margins are modest.
How often is the VMD DVR analysis updated?
Our AI-powered analysis of Viemed Healthcare Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on May 16, 2026.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for VMD (Viemed Healthcare Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.